(Q40639670)

22 September 2017

New class of HIV integrase inhibitors that block viral replication in cell culture (English)

1 reference

22 September 2017

8

Zeger Debyser

0 references

Bénédicte Van Maele

3

Bénédicte Van Maele

0 references

Victor V. Tetz

Victor Tetz

4

0 references

Christophe Pannecouque

Christophe Pannecouque

1

0 references

Erik De Clercq

Erik De Clercq

6

0 references

Myriam Witvrouw

7

Myriam Witvrouw

1 reference

22 September 2017

2

Wim Pluymers

1 reference

22 September 2017

5

Peter Cherepanov

1 reference

PubMed ID

12176326

22 September 2017

language of work or name

English

0 references

publication date

1 July 2002

1 reference

22 September 2017

1 reference

22 September 2017

12

1 reference

22 September 2017

14

1 reference

22 September 2017

1169-1177

1 reference

New developments in anti-HIV chemotherapy

22 September 2017

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

1 reference

7 January 2021

Requirement of active human immunodeficiency virus type 1 integrase enzyme for productive infection of human T-lymphoid cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

HIV-1 integration as a target for antiretroviral therapy: a review

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Reversal of Integration and DNA Splicing Mediated by Integrase of Human Immunodeficiency Virus

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Repair of gaps in retroviral DNA integration intermediates

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Modeling the late steps in HIV-1 retroviral integrase-catalyzed DNA integration

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

A high-throughput, non-radioactive microtiter plate assay for activity of the human immunodeficiency virus integrase protein

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

A novel assay for the DNA strand-transfer reaction of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Differential inhibition of HIV-1 preintegration complexes and purified integrase protein by small molecules

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Human immunodeficiency virus integration protein expressed in Escherichia coli possesses selective DNA cleaving activity

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Activities of human immunodeficiency virus (HIV) integration protein in vitro: specific cleavage and integration of HIV DNA

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Retroviral integrase inhibitors year 2000: update and perspectives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

HIV-1 integrase inhibitors: past, present, and future

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

T30177, an oligonucleotide stabilized by an intramolecular guanosine octet, is a potent inhibitor of laboratory strains and clinical isolates of human immunodeficiency virus type 1

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Mode of interaction of G-quartets with the integrase of human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Human immunodeficiency virus glycoprotein gp120 as the primary target for the antiviral action of AR177 (Zintevir).

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Inhibitors of HIV-1 replication [corrected; erratum to be published] that inhibit HIV integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Resistance to the anti-human immunodeficiency virus type 1 compound L-chicoric acid results from a single mutation at amino acid 140 of integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Inhibition of HIV-1 integrase by flavones, caffeic acid phenethyl ester (CAPE) and related compounds

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Effects of tyrphostins, protein kinase inhibitors, on human immunodeficiency virus type 1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

(-)-Arctigenin as a lead structure for inhibitors of human immunodeficiency virus type-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Hydroxylated aromatic inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Inhibition of human immunodeficiency virus type-1 integrase by curcumin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Antiretroviral agents as inhibitors of both human immunodeficiency virus type 1 integrase and protease.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Potent inhibitors of human immunodeficiency virus type 1 integrase: identification of a novel four-point pharmacophore and tetracyclines as novel inhibitors.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Inhibitors of human immunodeficiency virus integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Inhibition of the in vitro integration of Moloney murine leukemia virus DNA by the DNA minor groove binder netropsin

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Alternate strand DNA triple helix-mediated inhibition of HIV-1 U5 long terminal repeat integration in vitro

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Peptide inhibitors of HIV-1 integrase dissociate the enzyme oligomers

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Structure-activity relationships and binding mode of styrylquinolines as potent inhibitors of HIV-1 integrase and replication of HIV-1 in cell culture

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Thiazolothiazepine inhibitors of HIV-1 integrase

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Inhibitors of strand transfer that prevent integration and inhibit HIV-1 replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Structure of the HIV-1 integrase catalytic domain complexed with an inhibitor: a platform for antiviral drug design

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

4-Aryl-2,4-dioxobutanoic acid inhibitors of HIV-1 integrase and viral replication in cells

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

In vivo gene delivery and stable transduction of nondividing cells by a lentiviral vector

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

Multiply attenuated lentiviral vector achieves efficient gene delivery in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

An antiviral target on reverse transcriptase of human immunodeficiency virus type 1 revealed by tetrahydroimidazo-[4,5,1-jk] [1,4]benzodiazepin-2 (1H)-one and -thione derivatives

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

A two plasmid co-expression system in Escherichia coli for the production of virion-like reverse transcriptase of the human immunodeficiency virus type 1.

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

A quantitative assay for HIV DNA integration in vivo

1 reference

https://api.crossref.org/works/10.1016%2FS0960-9822%2802%2900952-1

7 January 2021

10.1016/S0960-9822(02)00952-1

Identifiers

DOI

1 reference

22 September 2017

1 reference

PubMed ID

12176326